Ibrutinib

From WikiMD.org
Jump to navigation Jump to search
Ibrutinib
TermIbrutinib
Short definitionibrutinib (i-BROO-tih-nib) A drug used alone or with other drugs to treat adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, Waldenstrom's macroglobulinemia (a type of non-Hodgkin lymphoma), mantle cell lymphoma or marginal zone lymphoma. It is also used to treat adults and children over 1 year old with chronic graft-versus-host disease. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


ibrutinib - (pronounced) (i-BROO-tih-nib) A drug used alone or with other drugs to treat adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, Waldenstrom's macroglobulinemia (a type of non-Hodgkin lymphoma), mantle cell lymphoma or marginal zone lymphoma. It is also used to treat adults and children over 1 year old with chronic graft-versus-host disease. It is also being studied in the treatment of other types of cancer. Ibrutinib blocks a protein called BTK, which can help prevent cancer cells from growing. It can also decrease the body's immune response. Ibrutinib is a type of tyrosine kinase inhibitor. Also called Imbruvica

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski